- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 275/04 - Heterocyclic compounds containing 1, 2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
Patent holdings for IPC class C07D 275/04
Total number of patents in this class: 169
10-year publication summary
8
|
8
|
7
|
10
|
7
|
11
|
7
|
3
|
7
|
4
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Amgen Inc. | 4118 |
8 |
Titan Chemicals Limited | 8 |
5 |
BASF SE | 21039 |
4 |
Emory University | 1641 |
4 |
Sumitomo Seika Chemicals Co., Ltd. | 1054 |
4 |
Yale University | 2422 |
4 |
Abbott Laboratories | 2397 |
3 |
Allergan, Inc. | 2334 |
3 |
FUJIFILM Corporation | 29702 |
3 |
CHDI Foundation, Inc. | 106 |
3 |
J-pharma Co., Ltd. | 26 |
3 |
Nippon Chemiphar Co., Ltd. | 232 |
3 |
Thor GmbH | 64 |
3 |
Troy Corporation | 45 |
3 |
Dethree Res. Lab. Inc. | 3 |
3 |
Zhejiang Jingxin Pharmaceutical Co., Ltd. | 22 |
3 |
The Regents of the University of California | 20137 |
2 |
Bayer Cropscience AG | 2009 |
2 |
Rohm and Haas Company | 2910 |
2 |
The Trustees of Columbia University in the City of New York | 3592 |
2 |
Other owners | 102 |